UCJ-24525-89322
2 vaccinations
1 coded response
6 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 832 / ID
- Registered
- 2020-12-30
- Relationship
- Self
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Moderna
- 2020-12-30
-
2020-12-31
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-31
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-01
Survey response — days 1–6 daily, dose 1MedDRA: Epistaxis — Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessFree text: Bloody noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-02
- 2021-01-03
- 2021-01-06
-
2021-01-07
Callback requested for5:00P EST
- 2021-01-12
- 2021-01-13
- 2021-01-15
-
2021-02-05
Dose 2 — Moderna
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Moderna | |
| 2 | 2021-02-05 | Moderna |
Call center
1 call center case
1 unsuccessful
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Bloody nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Epistaxis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release